Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
Authors
Keywords
Gene expression, Breast cancer, Breast tumors, Principal component analysis, Angiogenesis, VEGF signaling, Cancer treatment, Microarrays
Journal
PLoS One
Volume 8, Issue 5, Pages e61788
Publisher
Public Library of Science (PLoS)
Online
2013-05-09
DOI
10.1371/journal.pone.0061788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of class 3 semaphorins and their receptors in human breast neoplasia
- (2015) Carolyn A Staton et al. HISTOPATHOLOGY
- Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer
- (2012) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Semaphorin 7A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model
- (2012) Ramon C. Ghanem et al. CURRENT EYE RESEARCH
- Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
- (2012) Harry D. Bear et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models
- (2011) Andrea Casazza et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling
- (2011) B. Kigel et al. BLOOD
- MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A
- (2011) C. Urbich et al. BLOOD
- Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies
- (2011) Stacey D Finley et al. BMC Systems Biology
- A gene transcription signature of obesity in breast cancer
- (2011) Chad J. Creighton et al. BREAST CANCER RESEARCH AND TREATMENT
- 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
- (2011) N. Palaskas et al. CANCER RESEARCH
- The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
- (2011) J. J. Vredenburgh et al. CLINICAL CANCER RESEARCH
- Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
- (2011) A. M. Jubb et al. CLINICAL CANCER RESEARCH
- Basal Breast Cancer: A Complex and Deadly Molecular Subtype
- (2011) F. Bertucci et al. CURRENT MOLECULAR MEDICINE
- Semaphorin–plexin signalling genes associated with human breast tumourigenesis
- (2011) P.N. Gabrovska et al. GENE
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Neuropilin-1 expression in cancer and development
- (2011) Adrian M Jubb et al. JOURNAL OF PATHOLOGY
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
- (2011) Thomas Karn et al. PLoS One
- Subtype and pathway specific responses to anticancer compounds in breast cancer
- (2011) L. M. Heiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Endothelial Transcriptomics Identifies Semaphorin 3G as a Vascular Class 3 Semaphorin
- (2010) Simone Kutschera et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Furin Processing of Semaphorin 3F Determines Its Anti-Angiogenic Activity by Regulating Direct Binding and Competition for Neuropilin
- (2010) Matthew W. Parker et al. BIOCHEMISTRY
- Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
- (2010) Takayuki Iwamoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile
- (2010) K Graham et al. BRITISH JOURNAL OF CANCER
- Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
- (2010) A. Tabchy et al. CLINICAL CANCER RESEARCH
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
- (2010) Takayuki Iwamoto et al. JNCI-Journal of the National Cancer Institute
- Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-Ras
- (2010) A. Sakurai et al. MOLECULAR AND CELLULAR BIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-κB to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells
- (2009) Alfonso Catalano et al. CANCER RESEARCH
- Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis
- (2009) P. Gaur et al. CLINICAL CANCER RESEARCH
- Lymphangiogenic Characteristics of Triple Negativity in Node-Negative Breast Cancer
- (2009) Huan-Tao Liu et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- The Cleavage of Semaphorin 3C Induced by ADAMTS1 Promotes Cell Migration
- (2009) Cary Esselens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis
- (2009) Anguraj Sadanandam et al. MICROVASCULAR RESEARCH
- A compartment model of VEGF distribution in blood, healthy and diseased tissues
- (2008) Marianne O Stefanini et al. BMC Systems Biology
- Semaphorin 3B Inhibits the Phosphatidylinositol 3-Kinase/Akt Pathway through Neuropilin-1 in Lung and Breast Cancer Cells
- (2008) E. Castro-Rivera et al. CANCER RESEARCH
- Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases
- (2008) A. Varshavsky et al. CANCER RESEARCH
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started